Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 pri...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Diabetes Association
2018-02-01
|
Series: | Diabetes & Metabolism Journal |
Subjects: | |
Online Access: | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdf |
id |
doaj-44e3236d15b2460c9b6b302fc0a25be7 |
---|---|
record_format |
Article |
spelling |
doaj-44e3236d15b2460c9b6b302fc0a25be72020-11-25T00:32:44ZengKorean Diabetes AssociationDiabetes & Metabolism Journal2233-60792233-60872018-02-0142213714610.4093/dmj.2018.42.2.137Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass IndexKyoung Hwa Ha0Cheol Young Park1In Kyung Jeong2Hyun Jin Kim3Sang-Yong Kim4Won Jun Kim5Ji Sung Yoon6In Joo Kim7Dae Jung Kim8Sungrae Kim9Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.Department of Endocrinology and Metabolism, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea.Department of Internal Medicine, Chungnam National University School of Medicine, Daejeon, Korea.Department of Endocrinology and Metabolism, Chosun University Hospital, Chosun University College of Medicine, Gwangju, Korea.Department of Endocrinology and Metabolism, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.Department of Endocrinology and Metabolism, Yeungnam University College of Medicine, Daegu, Korea.Department of Endocrinology and Metabolism, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Korea.Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.Division of Endocrinology and Metabolism, Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Korea.BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 primary care clinics and hospitals nationwide from 2015 to 2016. The presence of insulin resistance and β-cell dysfunction was defined as a homeostatic model assessment of insulin resistance (HOMA-IR) value ≥2.5 and fasting C-peptide levels <1.70 ng/mL, respectively.ResultsA total of 75.1% and 22.6% of participants had insulin resistance and β-cell dysfunction, respectively. The proportion of participants with insulin resistance but no β-cell dysfunction increased, and the proportion of participants with β-cell dysfunction but no insulin resistance decreased as body mass index (BMI) increased. People diagnosed with diabetes before 40 years of age had significantly higher HOMA-IR and BMI than those diagnosed over 65 years of age (HOMA-IR, 5.0 vs. 3.0; BMI, 28.7 kg/m2 vs. 25.1 kg/m2). However, the β-cell function indices were lower in people diagnosed before 40 years of age than in those diagnosed after 65 years of age (homeostatic model assessment of β-cell function, 39.3 vs. 64.9; insulinogenic index, 10.3 vs. 18.7; disposition index, 0.15 vs. 0.25).ConclusionWe observed that the main pathogenic mechanism of type 2 diabetes is insulin resistance in participants with newly diagnosed type 2 diabetes. In addition, young adults with diabetes are more likely to have higher insulin resistance with obesity and have higher insulin secretory defect with severe hyperglycemia in the early period of diabetes than older populations.https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdfDiabetes mellitus, type 2Insulin resistanceInsulin secretion |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kyoung Hwa Ha Cheol Young Park In Kyung Jeong Hyun Jin Kim Sang-Yong Kim Won Jun Kim Ji Sung Yoon In Joo Kim Dae Jung Kim Sungrae Kim |
spellingShingle |
Kyoung Hwa Ha Cheol Young Park In Kyung Jeong Hyun Jin Kim Sang-Yong Kim Won Jun Kim Ji Sung Yoon In Joo Kim Dae Jung Kim Sungrae Kim Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index Diabetes & Metabolism Journal Diabetes mellitus, type 2 Insulin resistance Insulin secretion |
author_facet |
Kyoung Hwa Ha Cheol Young Park In Kyung Jeong Hyun Jin Kim Sang-Yong Kim Won Jun Kim Ji Sung Yoon In Joo Kim Dae Jung Kim Sungrae Kim |
author_sort |
Kyoung Hwa Ha |
title |
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index |
title_short |
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index |
title_full |
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index |
title_fullStr |
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index |
title_full_unstemmed |
Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index |
title_sort |
clinical characteristics of people with newly diagnosed type 2 diabetes between 2015 and 2016: difference by age and body mass index |
publisher |
Korean Diabetes Association |
series |
Diabetes & Metabolism Journal |
issn |
2233-6079 2233-6087 |
publishDate |
2018-02-01 |
description |
BackgroundWe evaluated the clinical characteristics of insulin resistance and β-cell dysfunction in newly diagnosed, drug-naive people with type 2 diabetes by analyzing nationwide cross-sectional data.MethodsWe collected the clinical data of 912 participants with newly diagnosed diabetes from 83 primary care clinics and hospitals nationwide from 2015 to 2016. The presence of insulin resistance and β-cell dysfunction was defined as a homeostatic model assessment of insulin resistance (HOMA-IR) value ≥2.5 and fasting C-peptide levels <1.70 ng/mL, respectively.ResultsA total of 75.1% and 22.6% of participants had insulin resistance and β-cell dysfunction, respectively. The proportion of participants with insulin resistance but no β-cell dysfunction increased, and the proportion of participants with β-cell dysfunction but no insulin resistance decreased as body mass index (BMI) increased. People diagnosed with diabetes before 40 years of age had significantly higher HOMA-IR and BMI than those diagnosed over 65 years of age (HOMA-IR, 5.0 vs. 3.0; BMI, 28.7 kg/m2 vs. 25.1 kg/m2). However, the β-cell function indices were lower in people diagnosed before 40 years of age than in those diagnosed after 65 years of age (homeostatic model assessment of β-cell function, 39.3 vs. 64.9; insulinogenic index, 10.3 vs. 18.7; disposition index, 0.15 vs. 0.25).ConclusionWe observed that the main pathogenic mechanism of type 2 diabetes is insulin resistance in participants with newly diagnosed type 2 diabetes. In addition, young adults with diabetes are more likely to have higher insulin resistance with obesity and have higher insulin secretory defect with severe hyperglycemia in the early period of diabetes than older populations. |
topic |
Diabetes mellitus, type 2 Insulin resistance Insulin secretion |
url |
https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-42-137.pdf |
work_keys_str_mv |
AT kyounghwaha clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT cheolyoungpark clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT inkyungjeong clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT hyunjinkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT sangyongkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT wonjunkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT jisungyoon clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT injookim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT daejungkim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex AT sungraekim clinicalcharacteristicsofpeoplewithnewlydiagnosedtype2diabetesbetween2015and2016differencebyageandbodymassindex |
_version_ |
1725319353721683968 |